Komatsu Junya, Imai Ryu-Ichiro, Nakaoka Yoko, Nishida Koji, Seki Shu-Ichi, Kubo Toru, Yamasaki Naohito, Kitaoka Hiroaki, Kubokawa Sho-Ichi, Kawai Kazuya, Hamashige Naohisa, Doi Yoshinori L
Department of Cardiology, Chikamori Hospital Kochi Japan.
Department of Cardiology and Aging Science, Kochi Medial School Kochi Japan.
Circ Rep. 2021 Apr 6;3(5):273-278. doi: 10.1253/circrep.CR-20-0101.
Although atrial fibrillation (AF) is a well-known risk factor for embolic stroke in hypertrophic cardiomyopathy (HCM), there is a paucity of information derived from HCM patients who have experienced embolic stroke. From 141 consecutive HCM patients who had been hospitalized between 2000 and 2018, the clinical characteristics and management of 86 patients with AF were analyzed retrospectively. The incidence of embolic stroke was 36% (n=31 patients). The median (interquartile range) age of embolic stroke was younger in male than female HCM patients (71 [64-80] vs. 83 [77-87] years, respectively; P=0.009). The prevalence of paroxysmal AF (74%) was significantly higher than that of chronic AF (26%) in 31 patients with embolic stroke (P=0.007). The CHADS score in patients with embolic stroke was not particularly useful in predicting the occurrence of embolic stroke. One-third of HCM patients with AF developed embolic stroke, and male HCM patients were younger at the time of the embolic stroke than female HCM patients. The prevalence of paroxysmal AF was significantly higher than that of chronic AF in patients with AF and embolic stroke. Early introduction of anticoagulation therapy is recommended at the first documentation of paroxysmal AF.
虽然心房颤动(AF)是肥厚型心肌病(HCM)患者发生栓塞性卒中的一个众所周知的危险因素,但关于经历过栓塞性卒中的HCM患者的信息却很少。对2000年至2018年间连续住院的141例HCM患者进行回顾性分析,分析了86例AF患者的临床特征及治疗情况。栓塞性卒中的发生率为36%(n = 31例患者)。男性HCM患者发生栓塞性卒中的年龄中位数(四分位间距)低于女性(分别为71[64 - 80]岁和83[77 - 87]岁;P = 0.009)。31例发生栓塞性卒中的患者中,阵发性AF的患病率(74%)显著高于慢性AF(26%)(P = 0.007)。CHADS评分对预测栓塞性卒中的发生并无特别作用。三分之一的HCM合并AF患者发生了栓塞性卒中,男性HCM患者发生栓塞性卒中时的年龄低于女性HCM患者。AF合并栓塞性卒中患者中,阵发性AF的患病率显著高于慢性AF。建议在首次记录阵发性AF时尽早开始抗凝治疗。